Topic: neurobiology

Prothena has missed primary and secondary endpoints in its key AL amyloidosis drug NEOD001 in a midstage test.

The agreement gives Roche a potential source of small molecule agonists of an undisclosed G-protein coupled receptor.

Scientists at Beth Israel Deaconess Medical Center are discovering why the process of feeling too full to eat any more goes awry in some people.